Stemline Therapeutics, Inc.
$69 M
Secondary/Follow-On
Joint Book-Runner
Joint Book-Runner
Sole Book-Runner
Sole Book-Runner
Sole Book-Runner
Placement Agent
Co-Manager
Co-Manager
Sole Book-Runner
Sole Book-Runner